Brief: Fulgent Genetics Q2 Revenue USD 71.028 Million
02/08/2024 12:00
Aug 02 (Reuters) - Fulgent Genetics Q2 operating income USD -18.906 million. * Q2 pretax profit USD -11.214 million * Q2 operating expenses USD 45.397 million * Q2 gross profit USD 26.491 million * Q2 core revenue USD 70.2 million
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview